Warning! GuruFocus detected
1 Severe warning sign
with ANEB.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Anebulo Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US0345691036
Description
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.95 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 48 | |||||
| 3-Year EPS without NRI Growth Rate | 28.5 | |||||
| 3-Year FCF Growth Rate | 4.4 | |||||
| 3-Year Book Growth Rate | -45.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -28.58 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.44 | |||||
| 9-Day RSI | 52.15 | |||||
| 14-Day RSI | 53.28 | |||||
| 3-1 Month Momentum % | -22.84 | |||||
| 6-1 Month Momentum % | -40.19 | |||||
| 12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.51 | |||||
| Quick Ratio | 17.51 | |||||
| Cash Ratio | 17.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -119.27 | |||||
| ROA % | -106.86 | |||||
| ROIC % | -1272.41 | |||||
| 3-Year ROIIC % | 664.07 | |||||
| ROC (Joel Greenblatt) % | -4854.9 | |||||
| ROCE % | -115.54 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.61 | |||||
| Price-to-Tangible-Book | 4.61 | |||||
| EV-to-EBIT | -6.72 | |||||
| EV-to-EBITDA | -6.72 | |||||
| EV-to-FCF | -9.98 | |||||
| Price-to-Net-Current-Asset-Value | 4.74 | |||||
| Price-to-Net-Cash | 4.88 | |||||
| Earnings Yield (Greenblatt) % | -14.88 | |||||
| FCF Yield % | -9.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ANEB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anebulo Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.28 | ||
| Beta | -1.15 | ||
| 3-Year Sharpe Ratio | -0.37 | ||
| 3-Year Sortino Ratio | -0.55 | ||
| Volatility % | 60.83 | ||
| 14-Day RSI | 53.28 | ||
| 14-Day ATR ($) | 0.247734 | ||
| 20-Day SMA ($) | 1.3835 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range ($) | 0.8001 - 3.3 | ||
| Shares Outstanding (Mil) | 41.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anebulo Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anebulo Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anebulo Pharmaceuticals Inc Frequently Asked Questions
What is Anebulo Pharmaceuticals Inc(ANEB)'s stock price today?
The current price of ANEB is $1.66. The 52 week high of ANEB is $3.30 and 52 week low is $0.80.
When is next earnings date of Anebulo Pharmaceuticals Inc(ANEB)?
The next earnings date of Anebulo Pharmaceuticals Inc(ANEB) is 2025-05-15 Est..
Does Anebulo Pharmaceuticals Inc(ANEB) pay dividends? If so, how much?
Anebulo Pharmaceuticals Inc(ANEB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers